Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration

AIDS. 2011 Jun 19;25(10):1333-6. doi: 10.1097/QAD.0b013e3283480144.

Abstract

We evaluated hepatitis C virus (HCV) treatment and the effect of treatment duration (24 versus 48 weeks) on treatment outcome among 50 HIV-infected men who have sex with men with acute HCV infection in Amsterdam. Overall sustained virological response (SVR) rate was 76%. Treatment duration was not significantly associated with SVR (adjusted odds ratio = 2.32; 95% confidence interval 0.39-13.97), suggesting that 24-week treatment may be sufficient for acute HCV infection in HIV-coinfected patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Drug Administration Schedule
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Hepatitis C / drug therapy*
  • Hepatitis C Antibodies / drug effects*
  • Homosexuality, Male
  • Humans
  • Male
  • Viral Load / drug effects*

Substances

  • Antiviral Agents
  • Hepatitis C Antibodies